Concerto Biosciences

📍 Cambridge, United States🗓 Founded 2020👥 30 employees💰 Last funded Feb 2022
Biotechnology Research🌐 concertobio.com
Website LinkedIn
Concerto Biosciences reinvents humanity’s relationship with microbes. We envision a future where each of us fine-tunes the microbial communities in us, on us, and around us to stay healthy. To pave the way, Concerto invented a platform to measure, in ultra-high throughput, how microbes behave in the presence of each other. These measurements enable Concerto to see the world as it is: a massive underlying network of microbial interactions that shapes the health of our bodies and our planet. The network reveals new products—“ensembles” of microbes that work in concert to perform tasks that benefit people. Our first ensembles rehabilitate the skin microbiome, providing protection from previously intractable diseases like eczema and restoring health to millions.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Hong Kong SAR
1
Investor activity2020–2022 · investors recorded per year
2020120222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Concerto Biosciences?
Concerto Biosciences has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Concerto Biosciences last raise funding?
The most recent investment in Concerto Biosciences recorded on gritt.io was in February 2022.
When was Concerto Biosciences founded?
Concerto Biosciences was founded in 2020.
What industry is Concerto Biosciences in?
Concerto Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Concerto Biosciences based?
Concerto Biosciences is headquartered in Cambridge, United States.